CEREZYME

Serial Number 74481041
Registration 1912218
800

Registration Progress

Application Filed
Jan 21, 1994
Under Examination
Dec 13, 1994
Approved for Publication
Aug 19, 1994
Published for Opposition
Sep 20, 1994
Registered
Aug 15, 1995

Attorney Assistance

Section 8 & 9 (30-Year) Renewal Due (Based on registration date 1995-08-15)
Due: Aug 15, 2025 13 days

Trademark Image

CEREZYME

Basic Information

Serial Number
74481041
Registration Number
1912218
Filing Date
January 21, 1994
Registration Date
August 15, 1995
Published for Opposition
September 20, 1994
Renewal Date
August 15, 2015
Drawing Code
1

Status Summary

Current Status
Active
Status Code
800
Status Date
Jan 21, 2016
Registration
Registered
Classes
005

Rights Holder

GENZYME CORPORATION

03
Address
450 WATER STREET
CAMBRIDGE, MA 02141

Ownership History

Genzyme Corporation

Original Applicant
03
Cambridge, MA

Genzyme Corporation

Owner at Publication
03
Cambridge, MA

Genzyme Corporation

Original Registrant
03
CAMBRIDGE, MA

GENZYME THERAPEUTIC PRODUCTS LIMITED PARTNERSHIP

New Owner After Registration #1
13
CAMBRIDGE, MA

GENZYME CORPORATION

New Owner After Registration #2
03
CAMBRIDGE, MA

Legal Representation

Attorney
Alexandra Kochian

USPTO Deadlines

Next Deadline
13 days remaining
Section 8 & 9 (30-Year) Renewal Due (Based on registration date 1995-08-15)
Due Date
August 15, 2025
Grace Period Ends
February 15, 2026

Application History

29 events
Date Code Type Description Documents
Jul 10, 2025 E89R I TEAS SECTION 8 & 9 RECEIVED Loading...
Jan 29, 2025 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Loading...
Aug 15, 2024 REM2 E COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED Loading...
Jan 8, 2020 CORV 1 REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED Loading...
Dec 10, 2019 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Apr 5, 2017 CORV 1 REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED Loading...
Jan 31, 2017 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jan 21, 2016 NA89 E NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED Loading...
Jan 21, 2016 RNL2 Q REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS) Loading...
Jan 21, 2016 89AG O REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED Loading...
Jan 21, 2016 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL Loading...
Nov 6, 2015 E89R I TEAS SECTION 8 & 9 RECEIVED Loading...
Oct 18, 2006 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Loading...
Mar 17, 2005 RNL1 Q REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS) Loading...
Mar 17, 2005 89AG O REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED Loading...
Feb 17, 2005 89AF I REGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED Loading...
Feb 17, 2005 E89R I TEAS SECTION 8 & 9 RECEIVED Loading...
Feb 17, 2005 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Nov 20, 2000 C15A O REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. Loading...
Sep 6, 2000 815F I REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED Loading...
Aug 15, 1995 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
May 31, 1995 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
May 10, 1995 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Apr 11, 1995 IUAF S USE AMENDMENT FILED Loading...
Dec 13, 1994 NOAM O NOA MAILED - SOU REQUIRED FROM APPLICANT Loading...
Sep 20, 1994 PUBO A PUBLISHED FOR OPPOSITION Loading...
Aug 19, 1994 NPUB O NOTICE OF PUBLICATION Loading...
Jun 13, 1994 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jun 7, 1994 DOCK D ASSIGNED TO EXAMINER Loading...

Detailed Classifications

Class 005
injectable pharmaceutical preparation to treat an enzyme deficiency caused by a genetic defect
First Use Anywhere: Jan 1, 1995
First Use in Commerce: Jan 1, 1995

Classification

International Classes
005